Lactoferrin for low iron: what comparisons with iron treatment show
A 2026 trial challenges older lactoferrin claims. Compare hemoglobin response, tolerability and the evidence for replacing conventional iron treatment.
Read articleFor informational and research purposes only.
Research, explained. Explore peptides, supplements, hormone health, longevity and red light therapy with clear, practical breakdowns of what the studies actually tell us.
Find a topic you’re curious about and take a closer look.
A 2026 trial challenges older lactoferrin claims. Compare hemoglobin response, tolerability and the evidence for replacing conventional iron treatment.
Read articleBiopsy findings, MRI liver-fat changes and weight loss answer different questions in survodutide's liver research.
Read articleThe phase 3 trial's treatment stops, continued follow-up and statistical analyses explain why its weight-loss estimates differ.
Read articleCOSMOS found small changes in two aging clocks. See what the trial measured and how its cognitive and disease-outcome results fit together.
Read articleThree randomized trials offer a more precise picture of semaglutide and alcohol use: improvements in some drinking measures, with important gaps in others.
Read articleThe STEP extension found substantial average weight regain after treatment ended. Learn what the numbers mean and how maintenance trials change the interpretation.
Read articleTesamorelin can reduce visceral fat while glucose still needs attention. Here is how the trials, diabetes signal and different blood tests fit together.
Read articleA 2025 feline trial separates changes in a blood marker from the outcome owners care about: remaining free of insulin treatment.
Read articleA randomized dog study supports two insulin options, while current guidance explains why the individual response and matching device still matter.
Read articleA small randomized trial supports studying different hospital insulin regimens for feline ketoacidosis. Its findings depend on intensive monitoring and cannot be reduced to a home injection schedule.
Read articleCranberry can be a prevention option for recurrent UTIs, but product differences and current symptoms require separate decisions.
Read articleTestosterone improved some bone measurements in earlier trials but did not prevent fractures in TRAVERSE. Here's how those results fit together.
Read article122–133 of 600 articles